Skip to main content

Wechselwirkungen zwischen Angiotensin II und dem sympathischen System

  • Conference paper
Angiotensin II — Antagonismus

Zusammenfassung

Angiotensin II (Ang II) interagiert mit dem sympathischen System auf verschiedenen Ebenen: Es steigert die exozytotische Freisetzung von Noradrenalin aus den sympathischen Varikositäten [28], erhöht die Freisetzung von Adrenalin aus dem Nebennierenmark, was einen ganglionären Angriffspunkt von Ang II nahelegt [24], es beeinflußt die Katecholaminfreisetzung im Zentralnervensystem [27] und verstärkt die Noradrenalinwirkung an der glatten Gefäßmuskulatur [3], Der letztgenannte Effekt wird dadurch ermöglicht, daß Ang II und Noradrenalin für die glattmuskuläre Kontraktion der Gefäße denselben „Second-messenger“, Inositoltriphosphat (IP3), benutzen [16]. Die geschilderten Wechselbeziehungen zwischen Ang II und dem sympathischen System lassen eine Differenzierung zwischen prä- und postsynaptischen Effekten erkennen: Zentrale, ganglionäre und postganglionäre Wirkungen an der Varikosität von Ang II am Sympathikus stehen als präsynaptische Effekte den postganglionären postsynaptischen Wirkungen an der glatten Muskulatur gegenüber.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brasch H, Sieroslawski L, Dominiak P (1993) Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension 22:699–704

    PubMed  CAS  Google Scholar 

  2. Chulak C, Couture R, Foucart S (1994) Bradykinin enhances the release of noradrenaline from rat atria through activation of a B2 receptor. Can J Physiol Pharmacol 72 (Suppl 1):458/P13.25

    Google Scholar 

  3. De Jonge A, Thoolen MJMC, Timmermans PBMWM, van Zwieten PA (1984) Interaction of angiotensin converting enzyme inhibitors with the sympathetic nervous system. Progr Pharmacol 5:25–38

    Google Scholar 

  4. Dendorfer A, Dominiak P (1995) Characterization of bradykinin receptors mediating catecholamine release in PC 12 cells. Naunyn Schmiedebergs Arch Pharmacol 351:274–281

    Article  PubMed  CAS  Google Scholar 

  5. Dominiak P (1993) Modulation of sympathetic control by ACE inhibitors. Eur Heart J 14 (Suppl I): 169–172

    PubMed  CAS  Google Scholar 

  6. Dominiak T, Blöchl A (1991) Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines? Basic Res Cardiol 86 (Suppl 3): 149–156

    PubMed  Google Scholar 

  7. Dominiak P, Elfrath A, Türck D (1987) Biosynthesis of catecholamines and sympathetic outflow in spontaneously hypertensive rats (SHR) after chronic treatment with CE blocking agents. J Cardiovasc Pharmacol 7:122–124

    Article  Google Scholar 

  8. Dominiak P, Elfrath A, Türck D (1987) Effects of chronic treatment with ramipril, a new ACE blocking agent on presynaptic sympathetic nervous system of SHR. Clin Exp Hypertens A9:369–373

    Article  CAS  Google Scholar 

  9. Dominiak P, Blöchl A, Ball B (1992) Actions of converting enzyme inhibitors on liver mitochondria of spontaneously hypertensive rats (SHR). Pharm Pharmacol Lett 2:20–23

    CAS  Google Scholar 

  10. Dominiak P, Simon M, Blöchl A, Brenner P (1992) Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and des Arg-bradykinin infusions: Influence of converting-enzyme inhibition. J Cardiovasc Pharmacol 20 (Suppl 9):S35–S38

    Article  PubMed  CAS  Google Scholar 

  11. Dominiak P, Brenner P, Simon M, Blöchl A (1994) Angiotensin I increases adrenaline release and Angiotensin II noradrenaline overflow in control and kininogen deficient Brown-Norway rats. Pharm Pharmacol Lett 4:23–26

    CAS  Google Scholar 

  12. Dzau VJ, Ingelfinger JR, Pratt RE (1986) Regulation of tissue renin and angiotensin gene expression. J Cardiovasc Pharmacol 8 (Suppl 19): 11–16

    Article  Google Scholar 

  13. Dzau VJ, Sasamura H, Hein L (1993) Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens 11 (Suppl 3): S13–S18

    Article  CAS  Google Scholar 

  14. Erdös EG (1976) Thekinins. Biochem Pharmacol 25:1563–1569

    Article  PubMed  Google Scholar 

  15. Göthert M, Kollecker P (1986) Subendothelial beta2-adrenoceptors in the rat vena cava: Facilitation of noradrenaline release via local stimulation of angiotensin II synthesis. Naunyn Schmiedebergs Arch Pharmacol 334:156–165

    Article  PubMed  Google Scholar 

  16. Griendling KK, Berk BC, Ganz P, Gimbrone MA Jr, Alexander W (1987) Angiotensin II stimulation of vascular smooth muscle phosphoinositide metabolism. State of the art lecture. Hypertension 9 (Suppl III): 181–185

    Google Scholar 

  17. Häuser W, Falias D, Dominiak P (1994) Bradykinin induces catecholamine release in pithed spontaneously hypertensive rates (SHR) via B2-receptors. Can J Physiol Pharmacol 72 (Suppl 2):38/P1.7

    Google Scholar 

  18. Jackson B (1993) Autoradiographische Lokalisierung von Gewebs-Angiotensin-Conversions-Enzym. Ramiprileffekte am Herzen. In: Dominiak P (Hrsg) ACE-Hemmer: Pharmakologie, lokale Wirkungen — Organprotektion und klinische Anwendung. Arcis, München

    Google Scholar 

  19. Khairallah PhA (1972) Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed Proc 31:1351–1357

    PubMed  CAS  Google Scholar 

  20. Kuo Y-J, Keeton TK (1991) Captopril increases norepinephrine spillover rate in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 258:223–231

    PubMed  CAS  Google Scholar 

  21. Majewski H, Hedler L, Schurr C, Starke K (1984) Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol 6:888–896

    Article  PubMed  CAS  Google Scholar 

  22. Mulinari R, Benetos A, Gavras I, Gavras H (1988) Vascular and sympathoadrenal respones to Bradykinin and a Bradykinin analogue. Hypertension 11:754–757

    PubMed  CAS  Google Scholar 

  23. Nussberger J, Brunner DB, Waeber B, Brunner HR (1986) Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hyptertension 8:476–482

    CAS  Google Scholar 

  24. Peach MJ (1971) Adrenal medullary stimulation induced by angiotensin I, angiotensin II and analogues. Circ Res (Suppl II):II 107–11117

    Google Scholar 

  25. Peach MJ (1977) Renin-angiotensin system (1977) Biochemistry and mechanism of action. Physiol Rev 57:313–370

    PubMed  CAS  Google Scholar 

  26. Peach MJ, Bumpus FM, Khairallah PhA (1971) Release of adrenal catecholamines by angiotensin I. J Pharmacol Exp Ther 176:366–376

    PubMed  CAS  Google Scholar 

  27. Qadri F, Badoer E, Stadler T, Unger Th (1991) Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats. A brain micro-dialysis study. Brain Res 563:137–141

    Article  PubMed  CAS  Google Scholar 

  28. Starke K (1971) Action of angiotensin on uptake, release and metabolism of 14C-noradrenaline by isolated rabbit hearts. Eur J Pharmacol 14:112–113

    Article  PubMed  CAS  Google Scholar 

  29. Starke K, Peskar BA, Schumacher KA, Taube HD (1977) Bradykinin and postganglionic sympathetic transmission. Naunyn Schmiedebergs Arch Pharmacol 299:23–32

    Article  PubMed  CAS  Google Scholar 

  30. Starke K, Taube HD, Borowski E (1977) Presynaptic receptor systems in catecholaminergic transmission. Biochem Pharmacol 26:259–268

    Article  PubMed  CAS  Google Scholar 

  31. Staszewska-Barczak J, Vane JR (1967) The release of catecholamines from the adrenal medulla by peptides. Br J Pharmacol Chemother 30:655–667

    PubMed  CAS  Google Scholar 

  32. Timmermans PBMWM, Wong PC, Chiù AT et al. (1993) Angiotensin II receptors and Angiotensin II receptor antagonists. Pharmacol Rev 45:205–251

    PubMed  CAS  Google Scholar 

  33. Wong PC, Price WA, Chiù AT et al. (1990) Nonpeptide angiotensin II receptor antagonists: studies with EXP 9270 and DuP 753. Hypertension 15:823–834

    PubMed  CAS  Google Scholar 

  34. Zimmeramn BG (1978) Actions of angiotensin on adrenergic nerve endings. Fed Proc 37:199–202

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Dominiak, P., Sieroslawski, L., Brasch, H. (1996). Wechselwirkungen zwischen Angiotensin II und dem sympathischen System. In: Philipp, T., Schäfers, R.F. (eds) Angiotensin II — Antagonismus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79645-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79645-6_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-59088-0

  • Online ISBN: 978-3-642-79645-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics